Electronic Prior Authorization for Prescription Drugs — Challenges and Opportunities for Reform
Jing Luo, M.D., M.P.H., and Walid F. Gellad, M.D., M.P.H.
NEJM, March 4, 2023

Cost-Sharing Reform for Chronic Disease Treatments as a Strategy to Improve Health Care Equity and Value in the US
Utibe R. Essien, MD, MPH; Jay B. Lusk, BSc; Stacie B. Dusetzina, PhD
JAMA Health Forum, December 29, 2022

Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act
Walid F. Gellad, MD, MPH; Inmaculada Hernandez, PharmD, PhD
JAMA, October 18, 2022

Beyond Detecting and Understanding Disparities in Novel Diabetes Treatment: Need for a Major Shift in Pharmacoequity Research
Utibe R. Essien, MD, MPH; Donna L. Washington, MD, MPH; Michael J. Fine, MD, MSc
JAMA, September 6, 2022

Myocarditis and pericarditis risk after covid-19 vaccination
Jing Luo & Walid F Gellad
The BMJ, July 13, 2022

Accelerated Approval — Taking the FDA’s Concerns Seriously
Rachel E. Sachs, J.D., M.P.H., Julie M. Donohue, Ph.D., and Stacie B. Dusetzina, Ph.D.
NEJM, July 6, 2022

Meeting the Needs of Medicaid Beneficiaries With Substance Use Disorders in Managed Care
Julie M. Donohue, PhD
JAMA Health Forum, July 1, 2022

Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes
Jing Luo
The Conversation, May 9, 2022

Op-Ed: Why affirmative action bans hurt health equity
Utibe R Essien, Dan P Ly, and Anupam B Jena
Los Angeles Times, May 3, 2022

Myocarditis after vaccination against covid-19
Walid Gellad
The BMJ, December 16, 2021

Decomposition of Expenditures for Insulins Across the Distribution Chain—Insights Into Rising Prices?
Chester B. Good, MD, MPH; Inmaculada Hernandez, PharmD, PhD
JAMA Health Forum, November 5, 2021

Collaborative Public Health Strategies to Combat e-Cigarette Regulation Loopholes
Kar-Hai Chu, PhD; Tina Batra Hershey, JD, MPH; Jaime E. Sidani, PhD, MPH, CHES
JAMA Pediatrics, August 16, 2021

Reducing Low-Value Care and Improving Health Care Value
Allison H. Oakes, PhD; Thomas R. Radomski, MD, MS
JAMA, April 8, 2021

Other Voices: Vaccine distribution should not hold up school reopening
Elizabeth Miller & Julie Donohue
Pittsburgh Post-Gazette, February 14, 2020

More Safety Data Would Be Nice, But We Need a Vaccine Now
Walid Gellad
Wired, November 11, 2020

Confronting State Medicaid Drug Spending Pressures
Rachel E. Sachs, JD, MPH; Julie M. Donohue, PhD; Stacie B. Dusetzina, PhD
JAMA, October 9, 2020

COVID-19 and School Closures
Julie M. Donohue, PhD; Elizabeth Miller, MD, PhD
JAMA, July 29, 2020

A Test of Diversity — What USMLE Pass/Fail Scoring Means for Medicine
Quentin R. Youmans, M.D., Utibe R. Essien, M.D., M.P.H., and Quinn Capers, IV, M.D.
NEJM, June 18, 2020

Drug Shortages in the United States: Are Some Prices Too Low?
Inmaculada Hernandez, PharmD, PhD; Tina Batra Hershey, JD, MPH; Julie M. Donohue, PhD
JAMA, March 3, 2020

Adalimumab and the Challenges for Biosimilars
Walid F. Gellad, MD, MPH; Chester B. Good, MD, MPH
JAMA, October 23, 2019

Prescription 2020: Democratic Candidates And Drug Pricing
Rohan Chalasani, Julie M. Donohue, Walid F. Gellad
Health Affairs Blog, August 29, 2019

Senate Hearings On Drug Prices: Many Questions, Few (Useful) Answers
Inmaculada Hernandez, Walid F. Gellad
Health Affairs Blog, July 24, 2019

A New Safe Harbor — Turning Drug Rebates into Discounts in Medicare Part D
Walid F. Gellad, M.D., M.P.H., Molly Ennis, M.P.H., and Courtney C. Kuza, Ph.D., M.P.H.
The New England Journal of Medicine, April 3, 2019

On The Use Of List Prices In Drug Pricing Research
Inmaculada Hernandez, Walid Gellad
Health Affairs Blog, March 14, 2019

Treating Pain—The Cannabis Conundrum
Chester B. Good, MD, MPH; Natasha Parekh, MD, MS; Kavita Fischer, MD; James Schuster, MD; Chronis Manolis, RPh; William Shrank, MD, MSHS
Annals of Internal Medicine, January 8, 2019

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply
Inmaculada Hernandez, PharmD, PhD; Vinay Prasad, MD, MPH; Walid F. Gellad, MD, MPH
JAMA Oncology, October 11, 2018

Changes in Drug Pricing After Drug Shortages in the United States
Inmaculada Hernandez, PharmD, PhD; Shivani Sampathkumar, BS; Chester B. Good, MD, MPH; Aaron S. Kesselheim, MD, JD, MPH; William H. Shrank, MD, MSHS
Annals of Internal Medicine, September 18, 2018.

Doughnuts and Discounts – Changes to Medicare Part D under the Bipartisan Budget Act of 2018
Julie M. Donohue, PhD, and Haiden A. Huskamp, PhD
New England Journal of Medicine, May 24, 2018

Discounted Drugs for Needy Patients and Hospitals — Understanding the 340B Debate
Walid F. Gellad, MD, MPH, and A. Everette James, JD, MBA
New England Journal of Medicine, February 8, 2018